EP1143972A4 - Vorbeugung und behandlung von migräne und anderen rekursiven kopfschmerzen durch verwendung von mittels die leukotrien ltd4 rezeptoren blockieren - Google Patents

Vorbeugung und behandlung von migräne und anderen rekursiven kopfschmerzen durch verwendung von mittels die leukotrien ltd4 rezeptoren blockieren

Info

Publication number
EP1143972A4
EP1143972A4 EP99954908A EP99954908A EP1143972A4 EP 1143972 A4 EP1143972 A4 EP 1143972A4 EP 99954908 A EP99954908 A EP 99954908A EP 99954908 A EP99954908 A EP 99954908A EP 1143972 A4 EP1143972 A4 EP 1143972A4
Authority
EP
European Patent Office
Prior art keywords
migraine
prevention
treatment
receptor blocker
ltd4 receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99954908A
Other languages
English (en)
French (fr)
Other versions
EP1143972A1 (de
Inventor
Fred D Sheftell
Robert C Kevorkian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1999/023932 external-priority patent/WO2000021536A1/en
Publication of EP1143972A1 publication Critical patent/EP1143972A1/de
Publication of EP1143972A4 publication Critical patent/EP1143972A4/de
Withdrawn legal-status Critical Current

Links

EP99954908A 1998-10-13 1999-10-12 Vorbeugung und behandlung von migräne und anderen rekursiven kopfschmerzen durch verwendung von mittels die leukotrien ltd4 rezeptoren blockieren Withdrawn EP1143972A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10393398P 1998-10-13 1998-10-13
US103933P 1998-10-13
PCT/US1999/023932 WO2000021536A1 (en) 1999-10-12 1999-10-12 Prevention and treatment of migraine and other recurrent headaches using leukotriene ltd4 receptor blocker drugs

Publications (2)

Publication Number Publication Date
EP1143972A1 EP1143972A1 (de) 2001-10-17
EP1143972A4 true EP1143972A4 (de) 2004-07-28

Family

ID=56289951

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99954908A Withdrawn EP1143972A4 (de) 1998-10-13 1999-10-12 Vorbeugung und behandlung von migräne und anderen rekursiven kopfschmerzen durch verwendung von mittels die leukotrien ltd4 rezeptoren blockieren

Country Status (2)

Country Link
EP (1) EP1143972A4 (de)
CA (1) CA2350897A1 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016069A1 (en) * 1992-02-13 1993-08-19 Merck Frosst Canada Inc. (azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
WO1997019925A1 (en) * 1995-11-27 1997-06-05 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Quinoline derivatives containing a diol as leukotriene antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016069A1 (en) * 1992-02-13 1993-08-19 Merck Frosst Canada Inc. (azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
WO1997019925A1 (en) * 1995-11-27 1997-06-05 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Quinoline derivatives containing a diol as leukotriene antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0021536A1 *

Also Published As

Publication number Publication date
CA2350897A1 (en) 2000-04-20
EP1143972A1 (de) 2001-10-17

Similar Documents

Publication Publication Date Title
IL132388A0 (en) Kappa-opioid agonist compounds pharmaceutical compositions and method of prevention and treatment of pruritus therewith
AU3233400A (en) Fire suppression composition and device
IL127664A (en) Compositions for the treatment and prevention of cachexia
HUP0200429A2 (en) Soluble receptor br43x2 and methods of using
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
ZA988012B (en) Amino-substituted compounds methods and compositions for inhibiting parp activity
NZ299693A (en) 1,4-dioxino derivatives of indole and quinoline; pharmaceutical compositions
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
IL138888A0 (en) Pharmaceutical composition and combination preparation for immunosuppressive therapy
IL126308A0 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
PL336942A1 (en) Derivatives of quinoline-4-carboxamide as antagonists of nk-2 and nk-3 receptor
AU6435398A (en) Prevention and treatment of hepatocellular cancer
PL312079A1 (en) Derivatives of 3-phenyl isoquinolin-1 (2h)-one, method of obtaining them, therapeutic agent and pharmaceutical composition
IL128784A0 (en) Security network and system
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU7601400A (en) Treatment and prevention of hepatic disorders
PL345803A1 (en) Prevention of migraine recurrence
EP1143972A4 (de) Vorbeugung und behandlung von migräne und anderen rekursiven kopfschmerzen durch verwendung von mittels die leukotrien ltd4 rezeptoren blockieren
GB9904932D0 (en) Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
ZA9811840B (en) Methods and compositions for the treatment and prevention of tumors tumor-related disorders and cachexia
AU3438701A (en) Preparation and method for prevention of coccidiosis
GB2353471B (en) Composition for treating obesity and related disorders and using therof
IL143903A0 (en) Use of phanquinone for the treatment or prevention of memory impairment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010423

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040616

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060411